TITLE

ILIACUS MUSCLE HEMATOMA

AUTHOR(S)
Sigler, Luis
PUB. DATE
February 1970
SOURCE
Angiology;Feb1970, Vol. 21 Issue 2, p114
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Iliacus muscle hematoma occurred in a patient receiving heparin for thrombophlebitis. It seemed that when the patient hyperextended the hip when resting in bed, severe pain was produced in the right iliac area, with femoral nerve paralysis and a decrease in the hematocrit level. In the initial stage the anticoagulants must be discontinued and bed rest instituted while the pain is present; then progressive exercises are permitted. Apparently, this complication of heparin administration is a self-limited condition that resolves spontaneously in a few weeks.
ACCESSION #
16392162

 

Related Articles

  • Initial management of deep venous thrombosis in the outpatient setting. Groce, James B. // American Journal of Health-System Pharmacy;5/1/2008, Vol. 65 Issue 9, p866 

    The article relates the author's perspective concerning the management of deep venous thrombosis (DVT) with low-molecular-weight heparin (LMWH) in an outpatient setting. He contends that outpatient treatment with LMWH is well tolerated and effective and can result in overall cost savings. He...

  • Acute DVT: Long-Term Results of Conservative Treatment. Strandness Jr., D. Eugene // Vascular Surgery;May/Jun1997, Vol. 31 Issue 3, p309 

    Discusses the results of a study on a conservative treatment of acute deep-vein thrombosis (DVT). Use of heparin in the conventional therapy for a patient with acute DVT; Effectiveness of the initiation of anticoagulant therapy; Complications associated with DVT.

  • Case #2: Calf Vein Thrombosis.  // Vascular Surgery;May/Jun1997, Vol. 31 Issue 3, p332 

    Discusses a case study on calf vein thrombosis. Description of the patient who was used as subject; Result of the ultrasound test for deep venous thrombosis; Use of heparinization to treat the patient.

  • The influence of low molecular weight heparin on the expression of osteogenic growth factors in human fracture healing. Sarahrudi, Kambiz; Kaiser, Georg; Thomas, Anita; Michel, Mark; Wolf, Harald; Mousavi, Mehdi; Aharinejad, Seyedhossein // International Orthopaedics;May2012, Vol. 36 Issue 5, p1095 

    Purpose: Anticoagulant therapy with low molecular weight heparins (LMWH) and mechanical compression is considered the gold standard for the prevention of thrombosis. However, evidence exists that LMWHs impair bone metabolism. The aim of this study was therefore to analyse alterations in the...

  • Trombosis de la arteria renal en un recién nacido. Presentación de un caso y revisión. Torres, Ana Lucía; Torres, Javier; Cifuentes, Jorge Andrés // Colombia Medica;ene-mar2009, Vol. 40 Issue 1, p114 

    This report describes a newborn who presents high pressure values and absence of pulses in inferior extremities in his 4th day of life. Posterior to placement of umbilical arterial catheter, confirming diagnostic of thrombosis in aorta and left renal artery. A gamagraphy with MAG 3 was performed...

  • Prophylaxis for Thromboembolism in Hospitalized Medical Patients. Francis, Charles W. // New England Journal of Medicine;4/5/2007, Vol. 356 Issue 14, p1438 

    The article discusses whether an older man who presented to the hospital with fever, cough, and dyspnea should receive thromboprophylaxis. The patient exhibited risk factors for venous thromboembolism. Various treatments for venous thrombosis are described, including nonpharmacologic therapies...

  • THE TREATMENT OF VENOUS THROMBOSIS WITH HEPARIN. Artz, Curtis P.; Pulaski, Edwin J. // Angiology;Aug1953, Vol. 4 Issue 4, p321 

    Early diagnosis is the keynote to the successful treatment of deep venous thrombosis. It may be difficult to make a positive diagnosis in the early stage of the disease; however treatment must be started at the first appearance of signs and symptoms. To delay, in an attempt to make a more...

  • HEPARIN THERAPY. Ebell, Mark H. // Journal of Family Practice;May94, Vol. 38 Issue 5, p527 

    The article discusses research being done on weight-based heparin therapy. It references a study by R. A. Raschke et al published in the November 1, 1993 issue of the journal "Annals of Internal Medicine." Heparin is considered a treatment for thromboembolic disease. The study was conducted in...

  • Better VTE Prophylaxis. Speroff, Leon // OB/GYN Clinical Alert;Sep2008, Vol. 25 Issue 5, p38 

    Rivaroxaban is more effective for venous thrombosis prophylaxis than low-molecular-weight heparin.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics